We welcomed Dr. David Murphy to the Gaffney team in early 2021. He received his Ph.D. from Columbia University in New York, NY for his research on the effects of linked selection on genetic variation in the human genome. Dr. Murphy will be working closely with the rest of our team as we use high-throughput sequencing technologies to understand how genetic variation affects the epigenome and influences autoimmune disease pathology.